To address this issue, we performed gene expression studies detecting ABCB1, ABCG2, ABCC1, CYP1A2, CYP3A4 and CYP2B6 in systemic and NSCLC cellular models following exposure to tepotinib. This evidence concerns the gene ABCB1 and non-small cell lung carcinoma.